Бизнес · 01.06.19981 мин чтения
Implantation or Injectable Dosage Form New Animal Drugs; Lufenuron Suspension
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The NADA provides for subcutaneous use of lufenuron suspension in cats for control of flea populations.